Chris Rao

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Research Fellow

Contact

christopher.rao Website

Location

Summary

Publications

Citation

BibTex format

@techreport{Rao:2023,
author = {Rao, C},
booktitle = {Appeal Panel Decision: Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma},
publisher = {National Institute of Health and Care Excellence},
title = {Appeal Panel Decision: Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma [ID3795]},
url = {https://www.nice.org.uk/guidance/gid-ta10645/documents/appeal-decision},
year = {2023}
}

Download

RIS format (EndNote, RefMan)

TY  - RPRT
AU  - Rao,C
PB  - National Institute of Health and Care Excellence
PY  - 2023///
TI  - Appeal Panel Decision: Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma [ID3795]
T1  - Appeal Panel Decision: Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma
UR  - https://www.nice.org.uk/guidance/gid-ta10645/documents/appeal-decision
ER  -

Download